Induction of Suppressor Macrophages by 12-O-Tetradecanoylphorbol-13-Acetate in Phorbol Ester-Sensitive (SENCAR) and Resistant (B6C3F1) Mice

References

• Nathan C. F., Root R. K. Hydrogen peroxide release from mouse peritoneal macrophages. J. Exp. Med. 1977; 146: 1648
   PubMed Web of Science ®Google Scholar
• Brune K., Glatt M., Kälin H., Peskar B. A. Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature 1978; 274: 261
   PubMed Web of Science ®Google Scholar
• Metzger Z., Hoffeld J. T., Oppenheim J. J. Macrophage-mediated suppression I. Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol. 1980; 124: 983
   PubMed Web of Science ®Google Scholar
• Hoffeld J. T., Metzger Z., Oppenheim J. J. Oxygen-derived metabolites as a suppressor of immune responses in vitro. Lymphokines 1981; 2: 63
   Google Scholar
• Mastro A. M., Pepin K. G. Suppression of lectin-stimulated DNA synthesis in bovine lymphocytes by the tumor promoter 12-0-tetradecanoylphorbol-13-acetate. Cancer Res. 1980; 40: 3307
   PubMedGoogle Scholar
• Keller R. Suppression of natural antitumour defence mechanisms by phorbol esters. Nature 1979; 282: 729
   PubMedGoogle Scholar
• Goldfarb R. H., Herberman R. B. Natural killer cell reactivity: regulatory interactions among phorbol ester, interferon, cholera toxin, and retinoic acid. J. Immunol. 1981; 126: 2129
   PubMed Web of Science ®Google Scholar
• Slaga T. J. Mechanisms of Tumor Promotion. Volume II - Tumor Promotion and Skin Carcinogenesis, T. J. Slaga. CRC Press, Inc., Boca Raton, FL 1983; 1–16
   Google Scholar
• Fish L. A., Baxter C. S., Bash J. A. Inhibition of macrophage-induced tumor cell cytostasis and cytolysis by tumor-promoting phorbol diesters. Toxicology 1981; 19: 127
   PubMedGoogle Scholar
• Grim W., Barlin E., Leser H. G., Kramer W., Gemsa D. Induction of tumor cytostatic macrophages by 12-0-tetradecanoylphorbol-13-acetate (TPA). Clin. Immunol. Immunopathol. 1980; 17: 617
   PubMedGoogle Scholar
• Laskin D. L., Laskin J. D., Kessler F. K., Weinstein I. B., Carchman R. A. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters. Cancer Res. 1981; 41: 4523
   PubMedGoogle Scholar
• Kolb J. P.B., Senik A., Castagna M. In vitro stimulation of mouse NK activity by phorbol esters: a pathway different from interferon-induced activation. Cell. Immunol. 1981; 65: 258
   Google Scholar
• Trinchieri G., O'Brien T., Shade M., Perussia B. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity. J. Immunol. 1984; 133: 1869
   PubMedGoogle Scholar
• Eastin W. C. Dermal Carcinogenesis: Research Directions for Human Relevance. 1987, December 1-4th Austin, TX, in press
   Google Scholar
• Updyke L. W., Chuthaputti A., Pfeifer R. W., Yim G. K.W. Modulation of natural killer activity by 12-0-tetradecanoylphorbol-13-acetate and benzoyl peroxide in phorbol ester-sensitive (SENCAR) and resistant (B6C3F1) mice. Carcinogenesis 1988; 9: 1943
   PubMedGoogle Scholar
• Cerutti P. A. Response modification creates promotability in multistage carcinogenesis. Carcinogenesis 1988; 9: 519
   PubMedGoogle Scholar
• Baldwin R. W., Pimm M. V. BCG in tumor immunotherapy. Adv. Cancer Res. 1978; 28: 91
   PubMedGoogle Scholar
• Adams D. O., Marino P. A. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: The interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor. J. Immunol. 1981; 126: 981
   PubMedGoogle Scholar
• Chang Z. L., Bonvini E., Varesio L., Holden H. T., Herberman R. B. Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin. Cell. Immunol. 1988; 114: 282
   PubMedGoogle Scholar
• Toohey J. I. Macrophages and methylthio groups in lymphocyte proliferation. J. Supramol. Struc. Cell. Biochem. 1981; 17: 11
   PubMedGoogle Scholar
• Updyke L. W., Yoon H. A., Chuthaputti A. C., Pfeifer R. W., Yim G. K.W. Induction of interleukin-1 and tumor necrosis factor by 12-0-tetradecanoylphorbol-13-acetate in phorbol ester-sensitive (SENCAR) and resistant (B6C3F1) mice. Carcinogenesis, 10, in press
   PubMedGoogle Scholar
• Stuart R. K., Hamilton J. A., Sensenbrenner L. L., Moore M. A.S. Regulation of myelopoiesis in vitro partial replacement of colony-stimulating factors by tumor-promoting phorbol esters. Blood 1982; 57: 1032
   Google Scholar
• Greenberger J. S., Newburger P. E., Sakakeeny M. Phorbol myristate acetate stimulates macrophage differentiation and replication and alters granulopoiesis and leukemogenesis in long-term bone marrow culture. Blood 1980; 56: 368
   PubMed Web of Science ®Google Scholar
• Koury M. J., Balmain A., Pregnell I. B. Induction of granulocyte-macrophage colony-stimulating activity in mouse skin by inflammatory agents and tumor promoters. EMBO J. 1983; 2: 1877
   PubMedGoogle Scholar
• Schoof R. A., Baxter C. S. Topical application of a tumor promoter induces proliferation of an adherent cell population in murine spleen. Int. J. Immunopharmacol. 1986; 8: 455
   PubMedGoogle Scholar
• Abrams S. I., Bray R. A., Brahmi Z. Mechanism of action of phorbol myristate acetate on human natural killer cell activity. Cell. Immunol. 1983; 80: 230
   PubMedGoogle Scholar
• Seaman W. E., Gindhart T. D., Blackman M. A., Dalal B. Natural killing of tumor cells by human peripheral blood cells: suppression of killing in vitro by tumor-promoting phorbol diesters. J. Clin. Invest. 1981; 67: 1324
   PubMedGoogle Scholar